Reborn Entrepreneurial Giant

Cheetah Mitsubishi was officially established. In fact, the factory has already been built. Even the production line of Pajero has been moved from the old factory area and transformed into the production line of Qiancheng CS8.

Qu Li, who did not attend, naturally did not know about the grand occasion. The comments on the Internet are very interesting: In four years, Qiancheng, Mitsubishi and Changfeng seem to have changed a lot, as if nothing Change.

Qu Li is not noble, but he arranged for Fanxing Fund to investigate mRNA vaccine technology with some results, and the person in charge of this aspect will introduce some current status of biomedicine development at home and abroad.

Qu Li doesn't understand such a professional content. He only knows that the application of mRNA has great prospects. At first, it was very controversial. Later, um, let alone the later, anyway, this technology is a very important research direction for future biological vaccines. Vaccines, the most common applications are therapeutic antibodies and functional proteins.

The "mRNA Big Three" are Moderna, BioNTech and CureVac…

"I just want to know, if we invest in this direction, what is the chance of success? What plan do you have?" Qu Li was a little impatient, he couldn't understand, but he felt that two of the two companies were familiar and seemed to have great development prospects .

"Frontier biotechnology research and development is very risky. If we want to do it, it is best to separate R\u0026D and production, which in turn involves the CXO (pharmaceutical contract outsourcing) industry..."

"You just said, are there any companies in China that do it?"

"There are several companies, such as WuXi AppTec listed in the United States, Asymchem in Tianjing, Pharmaron in Beijing, and Tigermed in Hangzhou..."

"Find a way to buy shares and help them grow." Qu Li said without hesitation, this is the same as doing venture capital, investing in the entire CXO track.

The high investment in new drug research and development has prompted pharmaceutical companies to outsource all aspects of the new drug research and development and production process. For domestic pharmaceutical companies, this industry is a technology- and capital-intensive enterprise, and its professional capabilities can effectively improve the quality and efficacy consistency of "generic drugs". Simply put, it can "overtake on a curve" to improve the pharmaceutical capabilities of domestic pharmaceutical companies.

"Well, now only one company has been established to be responsible for the development of mRNA vaccines..."

Qu Li agreed, and then contacted the Xiangya School of Medicine of Central South University. This hospital, which was originally famous and powerful, has begun to lag behind. It is no need to guess that many elites have gone to places with more promising prospects.

Jumei Glory Future has cooperated with both universities in Huxiang. Of course, it is not limited to Huxiang. At most, the budget given here is more. Now the scale is not large and the requirements are strict, so he does not enjoy much preferential treatment.

Qu Li couldn't get in the way of communication with universities and hospitals. He showed his sincerity and donated money to the hospital to buy equipment.

The vaccine company invested and established by Fanxing Fund was established in Xingsha. Some outstanding talents are unwilling to join, so let them go to teach at Central South University, which can be regarded as an indirect connection between the school and the enterprise.

Then there is capital operation, investing in the three giants of mRNA and supporting domestic CXO companies. Some companies have gone public, and some companies are preparing to go public. Fortunately, it is in the early stage, and the cost of intervention at this stage does not seem to be high.

Invest first, and increase investment if the cooperation is happy. If he understands the high technology of the Internet, he is only ignorant of biomedical vaccines, so Qu Li didn't spend too much time on this matter. After all, he was just asking for a solution. Peace of mind.

Qiancheng Automobile is more important to him. Since the production capacity is insufficient, it is impossible to sell the Qiancheng CS8 at a price reduction. Next year's upgraded version can be postponed.

"How much did it go up?"

"Why don't you raise the minimum price by 30,000 to 180,000?"

"The lowest price of Volkswagen Tiguan is 190,000."

"Their 190,000 is a 1.4T engine, MT gearbox; ours is 1.8T, AT gearbox, and..."

No matter how you look at the configuration of the Volkswagen Tiguan, it is not good. Domestic brands are tens of thousands more expensive than those in the United States, but they are selling well. It can only be said that domestic brands are not strong.

We discussed product positioning and quality control. Qiancheng's two cars have sold for hundreds of thousands, and it is almost impossible that there will be no quality problems. For consumers, it is natural to solve problems. Internally, it is to find problems and solve them. Is there any problem in this process?

Qu Li had nothing to do, he walked over and over again in person.

At this time in Beijin, great changes took place within Glory. Sanjay Jia finally let his people wield their butcher knives to reorganize the corruption problem in Glory's supply chain from top to bottom.

BYD and Futukang OEM factories are the central nodes where everything meets. From bottom to top, Qu Li can communicate with the person in charge of the supplier in Xingsha, and can find problems in a timely manner and find the person who caused the problem.

Corruption within Glory is not shocking, but there are many violations. In the final analysis, it is the fault of decentralization. In the past few years, the focus was on improving "delivery capabilities", product quality was given priority, and the purchase price was not strictly controlled. With great power, corruption will naturally appear.

With the assistance of a consulting company, Mr. Qu Lilei has established a relatively complete process in Glory. There are strict requirements from corporate culture to values, including very competitive salaries. There are quite a few people who can work with peace of mind.

But since it is a large-scale anti-corruption campaign, it is difficult to conceal the news. From time to time, some messages are posted on the Internet, which makes people worry.

At this time, Glory, Jumei, and Qiancheng released semi-annual reports one after another, with mixed results. Jumei is the most stable development, and both platforms have maintained a growth rate of nearly 50%. The development of foreign e-commerce retail business is relatively slow, but the performance of self-owned brands is bright. eyes. Search and cloud computing are not bad, time WeChat domestic users are almost over 200 million, WeChat foreign users officially exceeded 100 million...

If jumei is almost all good news, then Honor is not good. IPhone sales almost surpassed Honor. Samsung and Nokia’s Android smartphones have seen a relatively large increase. However, tablet sales have begun to rise, more than half of iPads, notebook computers have increased significantly, and even other business revenues such as drones and self-balancing vehicles are rising, so it is mixed.

The sales volume of 170,000 units of Qiancheng Motors in half a year made the media exclaim the rise of domestic independent brands, and at the same time issued a capacity warning.

"The production capacity of Qiancheng fuel vehicles is 400,000, and this year may exceed 350,000. What will we do next year?"

"Have to wait half a year for the delivery of Qiancheng fuel vehicles?"

"Qiancheng reproduces the lack of production capacity, and Quli's planning ability has become the biggest obstacle..."

"Quli's lack of capacity has caused Qiancheng Motors to fall into a production capacity dilemma many times."

"Qiancheng Geometry's 100,000 production capacity in Beijin will be put into production next year, and the 300,000 base in Yangcheng is now breaking ground. Insufficient production capacity has become the biggest obstacle to the development of Qiancheng Automobile."

The online coverage of Qu Li has suddenly increased, but the stock market continues to trade at the daily limit. Someone broke the news that the net profit of each model of Qiancheng CS6 exceeded 6,000, and the net profit of each model of Qiancheng CS8 exceeded 12,000.